Copyright
©The Author(s) 2019.
World J Gastrointest Surg. Jun 27, 2019; 11(6): 287-295
Published online Jun 27, 2019. doi: 10.4240/wjgs.v11.i6.287
Published online Jun 27, 2019. doi: 10.4240/wjgs.v11.i6.287
Extended criteria | |
UCSF[28] | Single tumor ≤ 6.5 cm in diameter or no more than 3 lesions ≤ 4.5 cm in diameter, and total tumor diameter ≤ 8 cm |
Asan criteria[29] | ≤ 6 tumors, all ≤ 5 cm in diameter, and no gross vascular invasion |
Valencia criteria[30] | 1-3 tumors ≤ 5 cm and cumulative tumor burden ≤ 10 cm |
Up-to-7 criteria[14] | Sum of the sizes of the largest tumor (in cm) and the number of tumors ≤ 7 |
CUN criteria[31] | Single tumor ≤ 6 cm or up to 3 nodules ≤ 5 cm |
Mount-Sinai[32] | Any number of lesions, each is 5-7 cm in diameter |
Edmonton[33] | Number of single tumors ≤ 7, tumor ≤ 5 cm in diameter |
Dallas[34] | Single tumor diameter ≤ 6 cm or 2-4 tumors each ≤ 5 cm in diameter |
Tokyo[35] | ≤ 5 tumors not exceeding 5 cm in diameter |
Shanghai[36] | Single tumor ≤ 9 cm in diameter or no more than 3 nodules with the largest nodule ≤ 5 cm in diameter, overall tumor diameter ≤ 9 cm without extrahepatic metastasis, lymph node or macrovascular invasion |
- Citation: Mullath A, Krishna M. Hepatocellular carcinoma – time to take the ticket. World J Gastrointest Surg 2019; 11(6): 287-295
- URL: https://www.wjgnet.com/1948-9366/full/v11/i6/287.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v11.i6.287